-
Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-β oligomer-treated hippocampal
neurons
Oliver Takach, Trevor B. Gill, and Michael A. Silverman
Neurobiology of Aging
(2015)
36 :1378
-
At the Centennial of Michaelis and Menten, Competing Michaelis-Menten Steps Explain Effect of GLP-1 on Blood-Brain Transfer
and Metabolism of Glucose
Michael Gejl, Jørgen Rungby, Birgitte Brock, and Albert Gjedde
Basic & Clinical Pharmacology & Toxicology
(2014)
115 :162
-
DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
Edy Kornelius, Chih-Li Lin, Hsiu-Han Chang, Hsin-Hua Li, Wen-Nung Huang, Yi-Sun Yang, Ying-Li Lu, Chiung-Huei Peng, and Chien-Ning
Huang
CNS Neuroscience & Therapeutics
(2015)
21 :549
-
The expanding role of incretin-based therapies: how much should we expect?
M. Haluzik
Journal of Endocrinology
(2014)
221 :E1
-
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
Paula L. McClean and Christian Hölscher
Neuropharmacology
(2014)
86 :241
-
Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia
Huinan Zhang, Jingru Meng, Xubo Li, Shimeng Zhou, Di Qu, Ning Wang, Min Jia, Xue Ma, and Xiaoxing Luo
European Journal of Pharmaceutical Sciences
(2015)
70 :82
-
Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1
mice
Paula L. McClean, Jaishree Jalewa, and Christian Hölscher
Behavioural Brain Research
(2015)
293 :96
-
Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson’s disease
WeiZhen Liu, Yanwei Li, Jaishree Jalewa, Taylor Saunders-Wood, Lin Li, and Christian Hölscher
European Journal of Pharmacology
(2015)
:
-
Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson’s disease mouse model
YanFang Zhang, YiMei Chen, Lin Li, and Christian Hölscher
Behavioural Brain Research
(2015)
293 :107
-
Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice
Rachael Lennox, Peter R. Flatt, and Victor A. Gault
Peptides
(2014)
61 :38
-
The non-glycemic effects of incretin therapies on cardiovascular outcomes, cognitive function and bone health
Amir Hanna, Kim A Connelly, Robert G Josse, and Roger S McIntyre
Expert Review of Endocrinology & Metabolism
(2015)
10 :101
-
Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
D. Allan Butterfield, Fabio Di Domenico, and Eugenio Barone
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
(2014)
1842 :1693
-
Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice
Vladimer Darsalia, Anna Olverling, Martin Larsson, Shiva Mansouri, David Nathanson, Thomas Nyström, Thomas Klein, Åke Sjöholm,
and Cesare Patrone
Regulatory Peptides
(2014)
190-191 :25
-
Neuroprotective effects of geniposide on Alzheimer’s disease pathology
WeiZhen Liu, Guanglai Li, Christian Hölscher, and Lin Li
Reviews in the Neurosciences
(2015)
26 :
-
Obesity-associated biomarkers and executive function in children
Alison L. Miller, Hannah J. Lee, and Julie C. Lumeng
Pediatric Research
(2015)
77 :143
-
Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of
Parkinson’s disease
W. Liu, J. Jalewa, M. Sharma, G. Li, L. Li, and C. Hölscher
Neuroscience
(2015)
303 :42
-
GLP-1 based therapeutics: simultaneously combating T2DM and obesity
Kristy M. Heppner and Diego Perez-Tilve
Frontiers in Neuroscience
(2015)
9 :
-
GLP-1 receptor agonist increases the expression of CTRP3, a novel adipokine, in 3T3-L1 adipocytes through PKA signal pathway
X. Li, L. Jiang, M. Yang, Y. Wu, S. Sun, and J. Sun
Journal of Endocrinological Investigation
(2015)
38 :73
-
Liraglutide Promotes Cortical Neurite Outgrowth via the MEK–ERK Pathway
Meng Li, Shilun Li, and Yukun Li
Cellular and Molecular Neurobiology
(2015)
:
-
Expression of CTRP3, a Novel Adipokine, in Rats at Different Pathogenic Stages of Type 2 Diabetes Mellitus and the Impacts
of GLP-1 Receptor Agonist on It
Xin Li, Li Jiang, Miao Yang, Yu-wen Wu, Su-xin Sun, and Jia-zhong Sun
Journal of Diabetes Research
(2014)
2014 :1
-
GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
Donna Ryan and Andres Acosta
Obesity
(2015)
23 :1119
-
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
Vladimer Darsalia, Martin Larsson, David Nathanson, Thomas Klein, Thomas Nyström, and Cesare Patrone
Journal of Cerebral Blood Flow & Metabolism
(2015)
35 :718
